Kevin C. Welch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kevin C. Welch has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Robert C. Kern
Northwestern University Feinberg School of Medicine
8 shared publications - Bruce K. Tan
Department of Otolaryngology Northwestern University Feinberg School of Medicine Chicago Illinois USA
7 shared publications - David B. Conley
Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL
7 shared publications - Stephanie Shintani Smith
Department of Otolaryngology Northwestern University Feinberg School of Medicine Chicago Illinois USA
7 shared publications - Anju Tripathi Peters
Division of Allergy and Immunology Feinberg School of Medicine Northwestern University Chicago Illinois USA
6 shared publications - Leslie C. Grammer
Northwestern University Feinberg School of Medicine
6 shared publications
Latest Publications
- Open Access
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 109-122
A Systematic Classification of Surgical Approaches for the Sphenoid Sinus: Establishing a Standardized Nomenclature for Endoscopic Sphenoid Sinus Surgery
The sphenoid sinus presents significant challenges during endoscopic sinus surgery. It is essential that surgeons employ strategies that effectively address sphenoid pathology while minimizing surgical risks and optimizing outcomes. Although nomenclature for maxillary and frontal sinus surgery is well established, there is currently no standardized nomenclature for sphenoid sinus surgery. We present a comprehensive review of techniques for accessing the sphenoid sinus and propose a common surgical classification system to better define and categorize these approaches. Each technique is classified based on surgical extent, anticipated operation time, complexity, potential complications, and expected wound healing, aligning with established standards in the literature. The proposed sphenoidotomy types are as follows: type I, sphenoid ostial dilation; type IIa, transnasal sphenoidotomy (sphenoidotomy without ethmoidectomy); type IIb, transethmoidal sphenoidotomy (sphenoidotomy with ethmoidectomy); type III, bilateral, common cavity sphenoidotomy, or “sphenoid drill-out;” type IV, transpterygoid approach, to expose the lateral sphenoid sinus recess; and type V, sphenoid nasalization, completely removing the sphenoid sinus floor. By standardizing the nomenclature for these techniques, we aim to enhance consistency in terminology for teaching, surgical planning, clinical research, and interdisciplinary communication in sphenoid sinus surgery.
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 109-122
Open AccessA Systematic Classification of Surgical Approaches for the Sphenoid Sinus: Establishing a Standardized Nomenclature for Endoscopic Sphenoid Sinus Surgery
The sphenoid sinus presents significant challenges during endoscopic sinus surgery. It is essential that surgeons employ strategies that effectively address sphenoid pathology while minimizing surgical risks and optimizing outcomes. Although nomenclature for maxillary and frontal sinus surgery is well established, there is currently no standardized nomenclature for sphenoid sinus surgery. We present a comprehensive review of techniques for accessing the sphenoid sinus and propose a common surgical classification system to better define and categorize these approaches. Each technique is classified based on surgical extent, anticipated operation time, complexity, potential complications, and expected wound healing, aligning with established standards in the literature. The proposed sphenoidotomy types are as follows: type I, sphenoid ostial dilation; type IIa, transnasal sphenoidotomy (sphenoidotomy without ethmoidectomy); type IIb, transethmoidal sphenoidotomy (sphenoidotomy with ethmoidectomy); type III, bilateral, common cavity sphenoidotomy, or “sphenoid drill-out;” type IV, transpterygoid approach, to expose the lateral sphenoid sinus recess; and type V, sphenoid nasalization, completely removing the sphenoid sinus floor. By standardizing the nomenclature for these techniques, we aim to enhance consistency in terminology for teaching, surgical planning, clinical research, and interdisciplinary communication in sphenoid sinus surgery.
- Top Cited Papers
- 24 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (4) , 952-964
Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue
- 24 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (4) , 952-964
Top Cited PapersSingle cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue
- 10 November 2021
- Published by Springer Nature in Current Otorhinolaryngology Reports
- Vol. 9 (4) , 399-408
Update on the Evaluation and Management of Nasal Valve Collapse
- 10 November 2021
- Published by Springer Nature in Current Otorhinolaryngology Reports
- Vol. 9 (4) , 399-408
Update on the Evaluation and Management of Nasal Valve Collapse
- 28 July 2021
- Published by Springer Nature
- p. 93-100
A Cerebrospinal Fluid Leak Following Endoscopic Resection of a Frontal Sinus Osteoma
- 28 July 2021
- Published by Springer Nature
- p. 93-100
A Cerebrospinal Fluid Leak Following Endoscopic Resection of a Frontal Sinus Osteoma
- 16 March 2021
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 11 (9) , 1308-1320
Responsiveness and convergent validity of the chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure in CRS patients undergoing endoscopic sinus surgery
Background: The chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure is a 12‐item measure with previously demonstrated validity in chronic rhinosinusitis (CRS) patients receiving medical therapy. This study establishes the factor structure, responsiveness, and convergent validity of the CRS‐PRO following endoscopic sinus surgery (ESS).Methods: Northwestern CRS Subject Registry patients had pre‐ESS, 3‐month (n = 111; CRS without nasal polyps [CRSsNP] = 60, CRS with nasal polyps [CRSwNP] = 51), and 6‐month (n = 86; CRSsNP = 47, CRSwNP = 39) post‐ESS assessments where patients completed the CRS‐PRO, 22‐item Sino‐Nasal Outcome Test (SNOT‐22), and four Patient‐Reported Outcomes Measurement (PROM) Information System (PROMIS) short forms (general health measures). Patients had pre‐ESS objective testing (endoscopic and radiographic assessment). Factor analysis was conducted using principal axis factoring with varimax rotation on the baseline CRS‐PRO. The clinically important difference (CID) was estimated using both distribution‐based and anchor‐based methods.Results: Factor analysis found the CRS‐PRO comprised the “rhino‐psychologic,” “facial discomfort,” and “cough” factors, which were responsive to ESS and correlated with the other PROMs. The changes observed in the CRS‐PRO at 3 months had strong correlation with the corresponding changes in SNOT‐22 (r = 0.792, p < 0.0001) and moderate correlations with changes in PROMIS fatigue and sleep domains. These changes had a very large effect size (Cohen's d 1.44) comparable to the longer SNOT‐22 (Cohen's d 1.41) with slightly larger effect sizes observed in CRSwNP compared to CRSsNP patients. Similar convergent validity and responsiveness were observed in the 6‐month data. The CRS‐PRO CID was estimated to be between 5.0 and 7.5 (midpoint 6.0) using distribution‐based and anchor‐based methods.Conclusion: This study demonstrates the validity and responsiveness of the CRS‐PRO in subjects receiving ESS.
- 16 March 2021
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 11 (9) , 1308-1320
Responsiveness and convergent validity of the chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure in CRS patients undergoing endoscopic sinus surgery
Background: The chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure is a 12‐item measure with previously demonstrated validity in chronic rhinosinusitis (CRS) patients receiving medical therapy. This study establishes the factor structure, responsiveness, and convergent validity of the CRS‐PRO following endoscopic sinus surgery (ESS).Methods: Northwestern CRS Subject Registry patients had pre‐ESS, 3‐month (n = 111; CRS without nasal polyps [CRSsNP] = 60, CRS with nasal polyps [CRSwNP] = 51), and 6‐month (n = 86; CRSsNP = 47, CRSwNP = 39) post‐ESS assessments where patients completed the CRS‐PRO, 22‐item Sino‐Nasal Outcome Test (SNOT‐22), and four Patient‐Reported Outcomes Measurement (PROM) Information System (PROMIS) short forms (general health measures). Patients had pre‐ESS objective testing (endoscopic and radiographic assessment). Factor analysis was conducted using principal axis factoring with varimax rotation on the baseline CRS‐PRO. The clinically important difference (CID) was estimated using both distribution‐based and anchor‐based methods.Results: Factor analysis found the CRS‐PRO comprised the “rhino‐psychologic,” “facial discomfort,” and “cough” factors, which were responsive to ESS and correlated with the other PROMs. The changes observed in the CRS‐PRO at 3 months had strong correlation with the corresponding changes in SNOT‐22 (r = 0.792, p < 0.0001) and moderate correlations with changes in PROMIS fatigue and sleep domains. These changes had a very large effect size (Cohen's d 1.44) comparable to the longer SNOT‐22 (Cohen's d 1.41) with slightly larger effect sizes observed in CRSwNP compared to CRSsNP patients. Similar convergent validity and responsiveness were observed in the 6‐month data. The CRS‐PRO CID was estimated to be between 5.0 and 7.5 (midpoint 6.0) using distribution‐based and anchor‐based methods.Conclusion: This study demonstrates the validity and responsiveness of the CRS‐PRO in subjects receiving ESS.
- Open Access
- 1 February 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (2) , AB3
Identification of severe eosinophilic chronic rhinosinusitis based on eosinophil, mast cell and basophil microparticles in nasal lavage fluids
- 1 February 2021
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 147 (2) , AB3
Open AccessIdentification of severe eosinophilic chronic rhinosinusitis based on eosinophil, mast cell and basophil microparticles in nasal lavage fluids
- 12 January 2021
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 11 (1) , 5
Valuing diversity, equity, and inclusion
- 12 January 2021
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 11 (1) , 5
Valuing diversity, equity, and inclusion
- Open Access
- 24 December 2020
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 100 (5) , 314-319
In-Office Corticosteroid Placement in the Management of Chronic Rhinosinusitis
Objectives: Corticosteroids represent one of the mainstays of medical management of chronic rhinosinusitis (CRS) in both locally acting topical and systemic derivations. The application of topical corticosteroids is limited by a variety of factors including patient compliance, positioning, and nasal anatomy. Systemic corticosteroids confer a risk of medical complication that restricts their ability to be used repeatedly. The objective of this publication is to review the evolution of the in-office intranasal placement of corticosteroids in the management of CRS. The efficacy, outcomes, and safety of a variety of corticosteroid-containing devices meant to be placed in an office setting are reviewed. Methods: Pertinent literature was reviewed and summarized beginning with the earliest reports of direct intralesional injection of corticosteroids up through manufactured modern-day bioresorbable implants that contain corticosteroids. Results: The utilization of in-office placement of corticosteroid-containing material and implants has rapidly evolved since the concept was introduced, particularly in the last decade. Modern-day corticosteroid-eluting implants are reliably placed in the office, yield results across a range of objective and subjective outcomes, may decrease the need for revision endoscopic sinus surgery, and have a favorable safety profile. Conclusions: In-office placement of corticosteroid-containing stents are a viable treatment option for select patients, particularly those wishing to avoid revision surgery, and should be considered an important adjunct for treatment of refractory CRS in an otolaryngologist’s armamentarium.
- 24 December 2020
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 100 (5) , 314-319
Open AccessIn-Office Corticosteroid Placement in the Management of Chronic Rhinosinusitis
Objectives: Corticosteroids represent one of the mainstays of medical management of chronic rhinosinusitis (CRS) in both locally acting topical and systemic derivations. The application of topical corticosteroids is limited by a variety of factors including patient compliance, positioning, and nasal anatomy. Systemic corticosteroids confer a risk of medical complication that restricts their ability to be used repeatedly. The objective of this publication is to review the evolution of the in-office intranasal placement of corticosteroids in the management of CRS. The efficacy, outcomes, and safety of a variety of corticosteroid-containing devices meant to be placed in an office setting are reviewed. Methods: Pertinent literature was reviewed and summarized beginning with the earliest reports of direct intralesional injection of corticosteroids up through manufactured modern-day bioresorbable implants that contain corticosteroids. Results: The utilization of in-office placement of corticosteroid-containing material and implants has rapidly evolved since the concept was introduced, particularly in the last decade. Modern-day corticosteroid-eluting implants are reliably placed in the office, yield results across a range of objective and subjective outcomes, may decrease the need for revision endoscopic sinus surgery, and have a favorable safety profile. Conclusions: In-office placement of corticosteroid-containing stents are a viable treatment option for select patients, particularly those wishing to avoid revision surgery, and should be considered an important adjunct for treatment of refractory CRS in an otolaryngologist’s armamentarium.
- 19 August 2020
- Published by Springer Nature
- p. 39-55
Asthma and Chronic Rhinosinusitis: Origins and Pathogenesis
- 19 August 2020
- Published by Springer Nature
- p. 39-55
Asthma and Chronic Rhinosinusitis: Origins and Pathogenesis
- Open Access
- 1 June 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (6) , 1598-1605
Clinical factors associated with acute exacerbations of chronic rhinosinusitis
- 1 June 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (6) , 1598-1605
Open AccessClinical factors associated with acute exacerbations of chronic rhinosinusitis